Private Equity/Financial services, healthcare, climate
LeapFrog Emerging Consumer Fund IV logo

LeapFrog Emerging Consumer Fund IV

Growth equity fund research profile

LeapFrog Emerging Consumer Fund IV is a global growth-equity vehicle investing in financial services and healthcare businesses serving emerging consumers, with current manager materials also showing climate investments in emerging markets. It is relevant to India-focused demand-side research because Fund IV publicly names Redcliffe Labs and the manager continues to disclose India deployment and impact evidence.

At a glance

Founded
2007
Footprint
London / global growth markets
Stage
Growth equity; emerging-market financial services, healthcare and climate solutions

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

LeapFrog Emerging Consumer Fund IV uses a growth equity; emerging-market financial services, healthcare and climate solutions approach across Financial services, healthcare, climate.

Current evidence

LeapFrog reported a US$1.02 billion Fund IV close in November 2024 and published 2025–2026 impact results. In March 2026, the manager announced a US$50 million commitment to ReNew Green through its climate strategy; that manager-level transaction is not counted as a Fund IV position here.

Strategy

Growth equity; emerging-market financial services, healthcare and climate solutions

Sector focus

Financial services, healthcare, climate

AIF structure context

Indian private equity, growth, buyout and many real-asset strategies are commonly structured as Category II AIFs. Verify the specific vehicle and registration before investing.

Current signal

LeapFrog reported a US$1.02 billion Fund IV close in November 2024 and published 2025–2026 impact results. In March 2026, the manager announced a US$50 million commitment to ReNew Green through its climate strategy; that manager-level transaction is not counted as a Fund IV position here.

Investor questions

LeapFrog Emerging Consumer Fund IV research questions

What is LeapFrog Emerging Consumer Fund IV's investment strategy?

LeapFrog Emerging Consumer Fund IV is covered in Rupeia's private equity research universe. The current public record describes the strategy as Growth equity; emerging-market financial services, healthcare and climate solutions, with a sector focus of Financial services, healthcare, climate. The profile should be read with the linked source trail and Typical route: Category II AIF context.

What portfolio evidence is available for LeapFrog Emerging Consumer Fund IV?

The profile displays only company or asset names attributable to LeapFrog Emerging Consumer Fund IV in the reviewed public sources: Redcliffe Labs, Sun King, bolttech. It does not represent a complete current portfolio unless the manager has published one.

What is known about LeapFrog Emerging Consumer Fund IV's performance or track record?

Fund IV's official announcement names Redcliffe Labs, Sun King and bolttech as investments. LeapFrog later reported a US$1.02 billion close, current portfolio-company growth and 2025–2026 impact and value-creation outcomes, but it does not publish fund-level IRR or MOIC. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.

What are LeapFrog Emerging Consumer Fund IV's fund size, fees and minimum investment?

Public fund size: US$1.02 billion including primary commitments and designated co-investments; the manager states that primary fund commitments were US$808 million and designated co-investment capacity up to US$210 million.. Public terms or access information: Growth equity for financial services and healthcare companies in global growth markets, with climate investing now part of the manager's broader strategy. Fees, carry, ownership and reserve terms are not publicly disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.

Who is on LeapFrog Emerging Consumer Fund IV's investment team?

The current source record names Dr Andy Kuper (Founder and CEO); Biju Mohandas (Partner); Nakul Zaveri (Partner). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.

What risks should be reviewed before investing with LeapFrog Emerging Consumer Fund IV?

Review entry valuation, leverage, governance rights, concentration, execution of the value-creation plan and exit timing. The current open diligence point is: Fund-level returns, fees, carry and the full Fund IV holdings schedule are not publicly disclosed. Only Redcliffe Labs, Sun King and bolttech are included because the manager's Fund IV announcement explicitly names them; later manager-level India spotlights such as Shubham and ReNew Green are excluded from the vehicle list where the public record does not identify the fund vehicle..

What is the latest public update on LeapFrog Emerging Consumer Fund IV?

2026-03-16: LeapFrog reported a US$1.02 billion Fund IV close in November 2024 and published 2025–2026 impact results. In March 2026, the manager announced a US$50 million commitment to ReNew Green through its climate strategy; that manager-level transaction is not counted as a Fund IV position here.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →